Journal article icon

Journal article

Monoclonal antibodies in immune and inflammatory diseases.

Abstract:
The era of monoclonal antibody-based therapeutics has arrived. Monoclonal antibodies of high quality targeting almost any antigen can now be engineered and manufactured in large quantities. In the clinic, monoclonal antibodies are proving to be safe and effective for the treatment of a wide range of diseases including rheumatoid arthritis, Crohn's disease, spondyloarthropathies, psoriasis and allograft rejection.
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDORMS
Role:
Author
Journal:
Current opinion in biotechnology
Volume:
13
Issue:
6
Pages:
615-620
Publication date:
2002-12-05
DOI:
EISSN:
1879-0429
ISSN:
0958-1669
URN:
uuid:6d6e44e9-4222-4030-bbe6-709ac904afe9
Source identifiers:
224412
Local pid:
pubs:224412

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP